NCT02149381

Brief Summary

A total of 384 patients suffering from chronic depressive disorder will be randomized to receive treatment as usual, CBASP, or befriending for a period of five months. The primary outcome is change in Montgomery-Åsberg Depression Scale. Secondary outcomes include changes in self-reported psychiatric symptoms, biomarkers determined from venous blood samples, and neurophysiological parameters. The data gathering is performed at pre- and post intervention stages (i.e., at baseline and at five months). A follow-up questionnaire is sent to the participants six months after the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started May 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2014

Completed
24 days until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
28 days until next milestone

First Posted

Study publicly available on registry

May 29, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

November 24, 2017

Status Verified

November 1, 2017

Enrollment Period

2 years

First QC Date

April 7, 2014

Last Update Submit

November 22, 2017

Conditions

Keywords

Depressiontreatment as usualCBASPbefriending

Outcome Measures

Primary Outcomes (1)

  • Depression

    Montgomery-Åsberg Depression Rating Scale

    At baseline and after intervention (at 5 months)

Secondary Outcomes (1)

  • Peripheral blood biomarkers

    At baseline and after intervention (at 5 mos)

Other Outcomes (1)

  • Neurophysiological measurements.

    At baseline and after intervention (5 mos)

Study Arms (3)

CBASP

EXPERIMENTAL

Cognitive Behavioral System of Psychotherapy is a manual-based group intervention for chr depression (20 weeks).

Behavioral: CBASPOther: Treatment as usual

Befriending

ACTIVE COMPARATOR

Befriending is a social support intervention

Behavioral: CBASPOther: Treatment as usual

Treatment as usual

ACTIVE COMPARATOR

Conventional psychiatric outpatient treatment (individual counseling)

Behavioral: CBASPBehavioral: Befriending

Interventions

CBASPBEHAVIORAL

Cognitive behavioral group intervention for individuals suffering from chronic depression

BefriendingCBASPTreatment as usual
BefriendingBEHAVIORAL

Social support intervention, sessions once per week

Treatment as usual

Conventional psychiatric outpatient treatment (individual counseling)

BefriendingCBASP

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65
  • Moderate or severe major depression with duration of a minimum of two years OR "double depression" (dysthymia and moderate/severe major depression simultaneously) OR moderate or severe major depression with duration of a minimum of two years, only partially remitted during the time period

You may not qualify if:

  • Psychotic disorder
  • Bipolar disorder
  • Current substance abuse (excluding nicotine)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Eastern Finland

Kuopio, Northern Savonia, 70211, Finland

Location

MeSH Terms

Conditions

Depression

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Soili Lehto, Professor

    University of Eastern Finland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2014

First Posted

May 29, 2014

Study Start

May 1, 2014

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

November 24, 2017

Record last verified: 2017-11

Locations